Melanie Cree
Concepts (381)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polycystic Ovary Syndrome | 25 | 2024 | 141 | 13.840 |
Why?
| Insulin Resistance | 59 | 2024 | 1072 | 11.310 |
Why?
| Diabetes Mellitus, Type 2 | 31 | 2023 | 2097 | 4.490 |
Why?
| Obesity | 29 | 2024 | 2513 | 4.010 |
Why?
| Mitochondria, Muscle | 11 | 2024 | 93 | 3.960 |
Why?
| Blood Glucose | 37 | 2023 | 1821 | 3.690 |
Why?
| Pediatric Obesity | 10 | 2024 | 489 | 2.990 |
Why?
| Glucose Intolerance | 11 | 2021 | 138 | 2.990 |
Why?
| Muscle, Skeletal | 30 | 2024 | 1472 | 2.760 |
Why?
| Glucose Clamp Technique | 16 | 2023 | 181 | 2.740 |
Why?
| Metformin | 10 | 2021 | 277 | 2.470 |
Why?
| Adolescent | 72 | 2024 | 17808 | 2.370 |
Why?
| Glucose Tolerance Test | 20 | 2023 | 343 | 2.340 |
Why?
| Testosterone | 7 | 2024 | 343 | 2.330 |
Why?
| Liver | 12 | 2023 | 1631 | 2.260 |
Why?
| Insulin | 26 | 2024 | 2079 | 2.100 |
Why?
| Triglycerides | 9 | 2022 | 470 | 2.050 |
Why?
| Hyperandrogenism | 3 | 2024 | 14 | 2.030 |
Why?
| Fatty Liver | 4 | 2024 | 213 | 1.950 |
Why?
| Diabetes Mellitus, Type 1 | 17 | 2024 | 3248 | 1.770 |
Why?
| Fatty Acids, Nonesterified | 7 | 2018 | 151 | 1.690 |
Why?
| Metabolic Syndrome | 3 | 2020 | 323 | 1.660 |
Why?
| Burns | 9 | 2010 | 237 | 1.600 |
Why?
| Female | 91 | 2024 | 59507 | 1.560 |
Why?
| Body Mass Index | 11 | 2024 | 1958 | 1.480 |
Why?
| Lipid Metabolism | 6 | 2019 | 446 | 1.480 |
Why?
| Lipolysis | 4 | 2019 | 39 | 1.440 |
Why?
| Young Adult | 35 | 2024 | 10463 | 1.410 |
Why?
| Hyperinsulinism | 4 | 2019 | 103 | 1.380 |
Why?
| Fasting | 6 | 2022 | 242 | 1.330 |
Why?
| Adipose Tissue | 6 | 2022 | 539 | 1.310 |
Why?
| Child | 47 | 2022 | 18352 | 1.280 |
Why?
| Magnetic Resonance Spectroscopy | 9 | 2024 | 473 | 1.250 |
Why?
| Humans | 113 | 2024 | 114756 | 1.230 |
Why?
| Oxidative Phosphorylation | 4 | 2019 | 156 | 1.210 |
Why?
| Cross-Sectional Studies | 21 | 2021 | 4409 | 1.200 |
Why?
| Glycerol | 6 | 2023 | 84 | 1.200 |
Why?
| Hypoglycemic Agents | 9 | 2019 | 1009 | 1.190 |
Why?
| Glucose | 10 | 2023 | 897 | 1.080 |
Why?
| Insulin-Secreting Cells | 6 | 2020 | 317 | 1.030 |
Why?
| Exercise | 12 | 2024 | 1644 | 1.030 |
Why?
| Case-Control Studies | 15 | 2024 | 3005 | 1.010 |
Why?
| Body Composition | 6 | 2024 | 592 | 1.010 |
Why?
| Cardiovascular Diseases | 6 | 2019 | 1727 | 0.960 |
Why?
| Gastrointestinal Microbiome | 2 | 2021 | 501 | 0.920 |
Why?
| Male | 66 | 2024 | 55579 | 0.910 |
Why?
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 117 | 0.900 |
Why?
| Androgens | 2 | 2022 | 167 | 0.870 |
Why?
| Prediabetic State | 4 | 2021 | 220 | 0.870 |
Why?
| Circadian Rhythm | 4 | 2019 | 355 | 0.870 |
Why?
| Transition to Adult Care | 1 | 2024 | 63 | 0.850 |
Why?
| Adult | 42 | 2024 | 30548 | 0.840 |
Why?
| Hyperglycemia | 4 | 2021 | 292 | 0.830 |
Why?
| Non-alcoholic Fatty Liver Disease | 3 | 2021 | 245 | 0.800 |
Why?
| Adenosine Diphosphate | 2 | 2021 | 81 | 0.750 |
Why?
| Obesity, Morbid | 1 | 2024 | 197 | 0.740 |
Why?
| Klinefelter Syndrome | 1 | 2021 | 50 | 0.730 |
Why?
| Desogestrel | 1 | 2020 | 40 | 0.710 |
Why?
| Adolescent Medicine | 1 | 2020 | 33 | 0.700 |
Why?
| Lipogenesis | 2 | 2019 | 57 | 0.690 |
Why?
| Isotopes | 1 | 2019 | 27 | 0.680 |
Why?
| Energy Metabolism | 3 | 2024 | 729 | 0.670 |
Why?
| Endocrinology | 1 | 2020 | 69 | 0.660 |
Why?
| Inservice Training | 1 | 2020 | 105 | 0.660 |
Why?
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 37 | 0.650 |
Why?
| Absorptiometry, Photon | 6 | 2024 | 224 | 0.640 |
Why?
| Gluconeogenesis | 1 | 2019 | 62 | 0.640 |
Why?
| Mentors | 1 | 2020 | 156 | 0.630 |
Why?
| Obesity, Abdominal | 1 | 2018 | 37 | 0.630 |
Why?
| Mentoring | 1 | 2020 | 101 | 0.610 |
Why?
| Interprofessional Relations | 1 | 2020 | 249 | 0.600 |
Why?
| Gynecology | 1 | 2020 | 163 | 0.600 |
Why?
| Adiposity | 4 | 2018 | 457 | 0.600 |
Why?
| Fatty Acids | 2 | 2019 | 382 | 0.580 |
Why?
| Depressive Disorder | 1 | 2020 | 332 | 0.570 |
Why?
| Fenofibrate | 2 | 2007 | 24 | 0.570 |
Why?
| Amino Acids | 3 | 2019 | 448 | 0.570 |
Why?
| Lipoproteins, HDL | 1 | 2017 | 76 | 0.560 |
Why?
| Overweight | 5 | 2021 | 471 | 0.550 |
Why?
| Biodiversity | 1 | 2020 | 358 | 0.550 |
Why?
| Oxygen Consumption | 9 | 2024 | 588 | 0.550 |
Why?
| C-Peptide | 5 | 2019 | 138 | 0.550 |
Why?
| Hypolipidemic Agents | 2 | 2007 | 87 | 0.540 |
Why?
| Mitochondria | 5 | 2024 | 751 | 0.510 |
Why?
| Prognosis | 5 | 2020 | 3334 | 0.490 |
Why?
| Muscle Proteins | 7 | 2017 | 210 | 0.480 |
Why?
| Aging | 3 | 2019 | 1620 | 0.480 |
Why?
| Diabetes Mellitus | 2 | 2020 | 904 | 0.470 |
Why?
| Lipoproteins | 1 | 2015 | 160 | 0.470 |
Why?
| B-Lymphocytes | 1 | 2019 | 769 | 0.460 |
Why?
| Bacteria | 1 | 2020 | 726 | 0.460 |
Why?
| Decision Making | 1 | 2020 | 781 | 0.450 |
Why?
| Severity of Illness Index | 3 | 2020 | 2539 | 0.450 |
Why?
| Sleep | 3 | 2019 | 632 | 0.450 |
Why?
| Oxygen | 1 | 2018 | 853 | 0.440 |
Why?
| PPAR alpha | 3 | 2007 | 52 | 0.430 |
Why?
| Follow-Up Studies | 6 | 2020 | 4420 | 0.430 |
Why?
| Cardiorespiratory Fitness | 3 | 2024 | 35 | 0.430 |
Why?
| Risk Factors | 11 | 2021 | 8627 | 0.420 |
Why?
| Bed Rest | 2 | 2009 | 15 | 0.410 |
Why?
| Calorimetry, Indirect | 2 | 2024 | 69 | 0.390 |
Why?
| Cohort Studies | 7 | 2021 | 4901 | 0.390 |
Why?
| Insulin Glargine | 3 | 2019 | 73 | 0.390 |
Why?
| Cystic Fibrosis | 1 | 2020 | 955 | 0.370 |
Why?
| Puberty | 3 | 2024 | 135 | 0.370 |
Why?
| Hirsutism | 2 | 2021 | 10 | 0.350 |
Why?
| Cushing Syndrome | 1 | 2009 | 10 | 0.340 |
Why?
| Prospective Studies | 7 | 2020 | 6217 | 0.340 |
Why?
| Gastroplasty | 2 | 2021 | 26 | 0.340 |
Why?
| Algorithms | 2 | 2021 | 1468 | 0.340 |
Why?
| Magnetic Resonance Imaging | 5 | 2021 | 3039 | 0.340 |
Why?
| Diabetic Nephropathies | 3 | 2020 | 234 | 0.340 |
Why?
| Estradiol | 3 | 2022 | 455 | 0.330 |
Why?
| Middle Aged | 14 | 2024 | 26757 | 0.330 |
Why?
| Sleep Apnea, Obstructive | 1 | 2021 | 200 | 0.290 |
Why?
| Exercise Tolerance | 4 | 2017 | 213 | 0.290 |
Why?
| Protein Kinase C | 1 | 2008 | 275 | 0.270 |
Why?
| Retrospective Studies | 7 | 2021 | 12515 | 0.270 |
Why?
| Autoimmunity | 1 | 2012 | 814 | 0.260 |
Why?
| Diabetic Cardiomyopathies | 2 | 2016 | 34 | 0.260 |
Why?
| Carnitine | 3 | 2019 | 62 | 0.240 |
Why?
| Adiponectin | 2 | 2016 | 213 | 0.240 |
Why?
| Aged | 11 | 2020 | 19094 | 0.240 |
Why?
| Lipoproteins, VLDL | 1 | 2024 | 21 | 0.230 |
Why?
| Age Factors | 3 | 2020 | 2890 | 0.230 |
Why?
| Adenosine Triphosphate | 2 | 2021 | 431 | 0.230 |
Why?
| Basal Metabolism | 1 | 2024 | 46 | 0.230 |
Why?
| Lipids | 4 | 2017 | 582 | 0.220 |
Why?
| Leg | 5 | 2021 | 225 | 0.220 |
Why?
| Muscle Contraction | 3 | 2014 | 388 | 0.220 |
Why?
| Reproducibility of Results | 7 | 2023 | 2763 | 0.220 |
Why?
| Endocrine System Diseases | 1 | 2023 | 30 | 0.220 |
Why?
| Colorado | 5 | 2020 | 4086 | 0.220 |
Why?
| Muscle Strength | 2 | 2017 | 270 | 0.220 |
Why?
| Vascular Stiffness | 2 | 2019 | 407 | 0.220 |
Why?
| Gonadotropin-Releasing Hormone | 1 | 2024 | 188 | 0.210 |
Why?
| Biomarkers | 6 | 2019 | 3416 | 0.210 |
Why?
| Sex Factors | 3 | 2017 | 1717 | 0.210 |
Why?
| Double-Blind Method | 3 | 2019 | 1662 | 0.200 |
Why?
| Carbon Isotopes | 4 | 2019 | 112 | 0.200 |
Why?
| Actigraphy | 2 | 2019 | 74 | 0.200 |
Why?
| Transgender Persons | 1 | 2024 | 134 | 0.200 |
Why?
| Sleep Wake Disorders | 2 | 2019 | 233 | 0.200 |
Why?
| Melatonin | 2 | 2019 | 105 | 0.190 |
Why?
| Phosphocreatine | 1 | 2021 | 36 | 0.190 |
Why?
| Glutathione | 1 | 2023 | 300 | 0.190 |
Why?
| Child, Preschool | 8 | 2022 | 9079 | 0.190 |
Why?
| Alopecia | 1 | 2021 | 28 | 0.190 |
Why?
| Bacteroidetes | 1 | 2021 | 20 | 0.190 |
Why?
| Time Factors | 5 | 2019 | 6124 | 0.180 |
Why?
| Body Weight | 2 | 2019 | 869 | 0.180 |
Why?
| Firmicutes | 1 | 2021 | 17 | 0.180 |
Why?
| Protein Biosynthesis | 2 | 2017 | 385 | 0.180 |
Why?
| Contraceptive Devices, Female | 1 | 2020 | 9 | 0.180 |
Why?
| Ovarian Reserve | 1 | 2020 | 13 | 0.180 |
Why?
| Sex Chromosome Disorders of Sex Development | 1 | 2020 | 9 | 0.180 |
Why?
| Drug Implants | 1 | 2020 | 70 | 0.180 |
Why?
| Carotid Intima-Media Thickness | 2 | 2018 | 65 | 0.180 |
Why?
| United States | 3 | 2021 | 12176 | 0.180 |
Why?
| Primary Ovarian Insufficiency | 1 | 2020 | 30 | 0.170 |
Why?
| Physicians, Women | 1 | 2020 | 55 | 0.170 |
Why?
| Glucose Metabolism Disorders | 1 | 2019 | 10 | 0.170 |
Why?
| Arginine | 2 | 2019 | 236 | 0.170 |
Why?
| Prednisolone | 1 | 2019 | 75 | 0.170 |
Why?
| Device Removal | 1 | 2020 | 126 | 0.170 |
Why?
| Liraglutide | 1 | 2019 | 27 | 0.160 |
Why?
| Aorta | 2 | 2019 | 386 | 0.160 |
Why?
| Sitagliptin Phosphate | 1 | 2019 | 30 | 0.160 |
Why?
| Amino Acids, Essential | 2 | 2009 | 12 | 0.160 |
Why?
| Predictive Value of Tests | 1 | 2024 | 1796 | 0.160 |
Why?
| Adrenocorticotropic Hormone | 1 | 2019 | 129 | 0.160 |
Why?
| Uromodulin | 1 | 2019 | 21 | 0.160 |
Why?
| Virilism | 1 | 2019 | 5 | 0.160 |
Why?
| Waist Circumference | 1 | 2019 | 122 | 0.160 |
Why?
| Menstruation Disturbances | 1 | 2019 | 12 | 0.160 |
Why?
| Sex Hormone-Binding Globulin | 1 | 2019 | 48 | 0.160 |
Why?
| Contraceptives, Oral | 1 | 2019 | 25 | 0.160 |
Why?
| Diastole | 1 | 2019 | 131 | 0.160 |
Why?
| Withholding Treatment | 1 | 2019 | 68 | 0.160 |
Why?
| Peer Group | 1 | 2020 | 201 | 0.160 |
Why?
| Spironolactone | 1 | 2019 | 28 | 0.160 |
Why?
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 44 | 0.160 |
Why?
| Respiratory Function Tests | 1 | 2020 | 524 | 0.160 |
Why?
| RNA, Ribosomal, 16S | 1 | 2021 | 485 | 0.160 |
Why?
| Erythrocytes | 1 | 2023 | 591 | 0.160 |
Why?
| Minority Groups | 1 | 2020 | 227 | 0.160 |
Why?
| Feces | 1 | 2021 | 374 | 0.160 |
Why?
| Deuterium | 3 | 2015 | 79 | 0.160 |
Why?
| Wakefulness | 1 | 2019 | 128 | 0.150 |
Why?
| Career Choice | 1 | 2020 | 177 | 0.150 |
Why?
| Intra-Abdominal Fat | 1 | 2018 | 77 | 0.150 |
Why?
| Cell Respiration | 1 | 2018 | 75 | 0.150 |
Why?
| Psychiatric Status Rating Scales | 1 | 2020 | 482 | 0.150 |
Why?
| Cardiotonic Agents | 1 | 2018 | 119 | 0.150 |
Why?
| Saliva | 1 | 2019 | 189 | 0.150 |
Why?
| Universities | 1 | 2020 | 339 | 0.150 |
Why?
| Spasms, Infantile | 1 | 2019 | 103 | 0.150 |
Why?
| Kidney | 4 | 2021 | 1184 | 0.150 |
Why?
| Incidence | 2 | 2021 | 2312 | 0.150 |
Why?
| Social Media | 1 | 2020 | 132 | 0.150 |
Why?
| Phosphorus Isotopes | 1 | 2017 | 8 | 0.140 |
Why?
| Occupational Exposure | 1 | 2020 | 255 | 0.140 |
Why?
| Child Behavior | 1 | 2019 | 220 | 0.140 |
Why?
| Blood Vessels | 1 | 2018 | 180 | 0.140 |
Why?
| Affect | 1 | 2019 | 246 | 0.140 |
Why?
| Hindlimb | 1 | 2017 | 130 | 0.140 |
Why?
| Prevalence | 2 | 2021 | 2249 | 0.140 |
Why?
| Parenting | 1 | 2020 | 251 | 0.140 |
Why?
| Social Support | 1 | 2020 | 528 | 0.140 |
Why?
| Human Development | 1 | 2016 | 14 | 0.140 |
Why?
| Societies, Medical | 1 | 2020 | 663 | 0.140 |
Why?
| Hospitals, Pediatric | 2 | 2017 | 479 | 0.140 |
Why?
| Bone Density | 1 | 2020 | 432 | 0.130 |
Why?
| Regional Blood Flow | 2 | 2016 | 424 | 0.130 |
Why?
| Placental Insufficiency | 1 | 2017 | 102 | 0.130 |
Why?
| Estrogens | 1 | 2019 | 312 | 0.130 |
Why?
| Metabolome | 1 | 2019 | 283 | 0.130 |
Why?
| Leptin | 1 | 2017 | 211 | 0.130 |
Why?
| Milk Proteins | 2 | 2006 | 36 | 0.130 |
Why?
| Schools | 1 | 2018 | 399 | 0.130 |
Why?
| Drug Therapy, Combination | 1 | 2018 | 954 | 0.130 |
Why?
| Glucocorticoids | 1 | 2019 | 532 | 0.120 |
Why?
| Pneumonia, Viral | 1 | 2020 | 340 | 0.120 |
Why?
| Life Style | 2 | 2018 | 430 | 0.120 |
Why?
| Coronavirus Infections | 1 | 2020 | 332 | 0.120 |
Why?
| Sex Characteristics | 2 | 2017 | 640 | 0.120 |
Why?
| Pulse Wave Analysis | 3 | 2021 | 207 | 0.120 |
Why?
| Exercise Therapy | 1 | 2018 | 351 | 0.120 |
Why?
| Glomerular Filtration Rate | 4 | 2020 | 604 | 0.120 |
Why?
| Phosphorus | 1 | 2014 | 81 | 0.110 |
Why?
| Metabolomics | 1 | 2019 | 527 | 0.110 |
Why?
| Surveys and Questionnaires | 2 | 2020 | 4625 | 0.110 |
Why?
| Biopsy | 2 | 2008 | 1040 | 0.110 |
Why?
| Inflammation Mediators | 1 | 2017 | 476 | 0.110 |
Why?
| Blood Pressure | 2 | 2017 | 1530 | 0.110 |
Why?
| Echocardiography | 1 | 2016 | 554 | 0.110 |
Why?
| Ventricular Function, Left | 1 | 2016 | 467 | 0.100 |
Why?
| Fetal Growth Retardation | 1 | 2017 | 467 | 0.100 |
Why?
| Area Under Curve | 3 | 2008 | 275 | 0.100 |
Why?
| Models, Biological | 1 | 2019 | 1630 | 0.100 |
Why?
| Emotions | 1 | 2017 | 472 | 0.100 |
Why?
| Physicians | 1 | 2020 | 772 | 0.100 |
Why?
| Pandemics | 1 | 2020 | 1319 | 0.100 |
Why?
| Models, Theoretical | 1 | 2015 | 516 | 0.100 |
Why?
| Pyruvic Acid | 2 | 2010 | 42 | 0.100 |
Why?
| Hypoglycemia | 1 | 2016 | 386 | 0.100 |
Why?
| Disease Progression | 2 | 2022 | 2387 | 0.100 |
Why?
| Hypertension | 1 | 2019 | 1059 | 0.100 |
Why?
| Linear Models | 2 | 2014 | 770 | 0.100 |
Why?
| Treatment Outcome | 6 | 2019 | 9089 | 0.090 |
Why?
| Creatinine | 3 | 2020 | 424 | 0.090 |
Why?
| Internship and Residency | 1 | 2020 | 932 | 0.090 |
Why?
| Jet Lag Syndrome | 1 | 2019 | 7 | 0.080 |
Why?
| Acyl Coenzyme A | 2 | 2006 | 30 | 0.080 |
Why?
| Quality Improvement | 1 | 2016 | 951 | 0.080 |
Why?
| Hypertriglyceridemia | 1 | 2008 | 34 | 0.080 |
Why?
| Diabetes, Gestational | 1 | 2012 | 281 | 0.080 |
Why?
| Palmitates | 1 | 2008 | 16 | 0.080 |
Why?
| Protein Kinase C beta | 1 | 2008 | 24 | 0.080 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 2 | 2005 | 162 | 0.080 |
Why?
| Risk Assessment | 1 | 2017 | 2973 | 0.070 |
Why?
| Hospitalization | 1 | 2016 | 1752 | 0.070 |
Why?
| Longitudinal Studies | 2 | 2024 | 2386 | 0.070 |
Why?
| Muscle Cells | 1 | 2007 | 42 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2005 | 472 | 0.070 |
Why?
| Albuminuria | 2 | 2020 | 164 | 0.070 |
Why?
| Acetates | 1 | 2007 | 95 | 0.070 |
Why?
| Trauma Severity Indices | 1 | 2007 | 110 | 0.070 |
Why?
| Animals | 8 | 2017 | 31761 | 0.070 |
Why?
| Islets of Langerhans | 1 | 2012 | 728 | 0.070 |
Why?
| Critical Care | 1 | 2010 | 473 | 0.070 |
Why?
| Phenylalanine | 4 | 2009 | 57 | 0.070 |
Why?
| Muscular Atrophy | 1 | 2006 | 78 | 0.070 |
Why?
| Carbon Dioxide | 1 | 2007 | 218 | 0.070 |
Why?
| Self Report | 1 | 2019 | 695 | 0.060 |
Why?
| Milk | 1 | 2006 | 124 | 0.060 |
Why?
| Oxidation-Reduction | 1 | 2008 | 927 | 0.060 |
Why?
| Caseins | 1 | 2004 | 20 | 0.060 |
Why?
| Cystatin C | 2 | 2014 | 62 | 0.060 |
Why?
| Albumins | 1 | 2005 | 89 | 0.060 |
Why?
| Fibrinogen | 1 | 2005 | 154 | 0.060 |
Why?
| Mitochondrial Diseases | 1 | 2024 | 77 | 0.060 |
Why?
| Physical Exertion | 1 | 2005 | 211 | 0.060 |
Why?
| Stress, Physiological | 1 | 2006 | 379 | 0.050 |
Why?
| Placebos | 2 | 2019 | 198 | 0.050 |
Why?
| Glycolysis | 1 | 2024 | 227 | 0.050 |
Why?
| Exercise Test | 3 | 2016 | 544 | 0.050 |
Why?
| Dietary Carbohydrates | 1 | 2003 | 139 | 0.050 |
Why?
| Critical Illness | 1 | 2007 | 643 | 0.050 |
Why?
| Culture Media, Conditioned | 1 | 2022 | 105 | 0.050 |
Why?
| Regression Analysis | 1 | 2004 | 946 | 0.050 |
Why?
| Pregnancy | 3 | 2020 | 5525 | 0.050 |
Why?
| Gonadotropins | 1 | 2020 | 37 | 0.040 |
Why?
| Hydroxyestrones | 1 | 2000 | 2 | 0.040 |
Why?
| Isoflavones | 1 | 2000 | 16 | 0.040 |
Why?
| Chromosomes, Human, X | 1 | 2020 | 60 | 0.040 |
Why?
| Sex Chromosome Aberrations | 1 | 2020 | 51 | 0.040 |
Why?
| Anti-Mullerian Hormone | 1 | 2020 | 50 | 0.040 |
Why?
| Parental Leave | 1 | 2020 | 17 | 0.040 |
Why?
| Trisomy | 1 | 2020 | 68 | 0.040 |
Why?
| Salaries and Fringe Benefits | 1 | 2020 | 52 | 0.040 |
Why?
| Practice Guidelines as Topic | 2 | 2017 | 1393 | 0.040 |
Why?
| Causality | 1 | 2019 | 104 | 0.040 |
Why?
| Administration, Oral | 3 | 2006 | 731 | 0.040 |
Why?
| Sulfonylurea Compounds | 1 | 2019 | 44 | 0.040 |
Why?
| Hormones | 1 | 2019 | 133 | 0.040 |
Why?
| Rats, Zucker | 2 | 2010 | 27 | 0.040 |
Why?
| Biological Transport | 2 | 2010 | 372 | 0.040 |
Why?
| Diabetic Angiopathies | 1 | 2019 | 244 | 0.030 |
Why?
| Magnetic Resonance Angiography | 1 | 2018 | 219 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2021 | 1691 | 0.030 |
Why?
| Infant, Newborn | 2 | 2020 | 5035 | 0.030 |
Why?
| Whey Proteins | 2 | 2006 | 5 | 0.030 |
Why?
| Physicians, Primary Care | 1 | 2018 | 222 | 0.030 |
Why?
| Echocardiography, Doppler | 1 | 2016 | 92 | 0.030 |
Why?
| Tertiary Care Centers | 1 | 2016 | 126 | 0.030 |
Why?
| Infant | 2 | 2019 | 7935 | 0.030 |
Why?
| Sheep | 1 | 2017 | 764 | 0.030 |
Why?
| Comorbidity | 1 | 2019 | 1449 | 0.030 |
Why?
| Oxidative Stress | 1 | 2021 | 1084 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2018 | 1340 | 0.030 |
Why?
| Rabbits | 2 | 2005 | 736 | 0.030 |
Why?
| Mothers | 1 | 2020 | 651 | 0.030 |
Why?
| Stress, Mechanical | 1 | 2016 | 445 | 0.030 |
Why?
| Weight Loss | 1 | 2018 | 642 | 0.030 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 127 | 0.030 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2014 | 184 | 0.030 |
Why?
| Biomechanical Phenomena | 1 | 2016 | 667 | 0.030 |
Why?
| Cholesterol, LDL | 1 | 2014 | 307 | 0.030 |
Why?
| Diet | 1 | 2000 | 1080 | 0.030 |
Why?
| Glucagon | 1 | 2012 | 93 | 0.030 |
Why?
| Parents | 1 | 2020 | 1190 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2014 | 1435 | 0.020 |
Why?
| Malonyl Coenzyme A | 1 | 2010 | 5 | 0.020 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2010 | 33 | 0.020 |
Why?
| Rats | 2 | 2010 | 4943 | 0.020 |
Why?
| Adaptation, Physiological | 1 | 2014 | 483 | 0.020 |
Why?
| Glycogen | 1 | 2010 | 51 | 0.020 |
Why?
| Sciatic Nerve | 1 | 2010 | 56 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2010 | 372 | 0.020 |
Why?
| Cholesterol, VLDL | 1 | 2008 | 4 | 0.020 |
Why?
| Clinical Protocols | 1 | 2010 | 232 | 0.020 |
Why?
| Primary Health Care | 1 | 2018 | 1515 | 0.020 |
Why?
| Lactic Acid | 1 | 2010 | 275 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 797 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2010 | 718 | 0.020 |
Why?
| Radioactive Tracers | 1 | 2007 | 3 | 0.020 |
Why?
| Citric Acid Cycle | 1 | 2007 | 43 | 0.020 |
Why?
| Sodium Bicarbonate | 1 | 2007 | 40 | 0.020 |
Why?
| Breath Tests | 1 | 2007 | 82 | 0.020 |
Why?
| Cholesterol | 1 | 2008 | 368 | 0.020 |
Why?
| Multienzyme Complexes | 1 | 2006 | 64 | 0.020 |
Why?
| Diglycerides | 1 | 2006 | 54 | 0.020 |
Why?
| Palmitoylcarnitine | 1 | 2005 | 1 | 0.020 |
Why?
| Methods | 1 | 2005 | 58 | 0.020 |
Why?
| Carbohydrate Sequence | 1 | 2005 | 23 | 0.020 |
Why?
| Palmitic Acid | 1 | 2005 | 36 | 0.020 |
Why?
| AMP-Activated Protein Kinases | 1 | 2006 | 175 | 0.020 |
Why?
| Reference Standards | 1 | 2005 | 159 | 0.020 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2006 | 278 | 0.020 |
Why?
| Dietary Supplements | 1 | 2008 | 460 | 0.020 |
Why?
| Metabolic Clearance Rate | 1 | 2005 | 102 | 0.020 |
Why?
| Weight Lifting | 1 | 2004 | 29 | 0.020 |
Why?
| Hydrocortisone | 1 | 2006 | 269 | 0.010 |
Why?
| Phenotype | 1 | 2012 | 2812 | 0.010 |
Why?
| Patient Discharge | 1 | 2010 | 769 | 0.010 |
Why?
| Leucine | 1 | 2004 | 102 | 0.010 |
Why?
| Fluorocarbons | 1 | 2005 | 94 | 0.010 |
Why?
| Chromatography, Liquid | 1 | 2005 | 348 | 0.010 |
Why?
| Heart Rate | 1 | 2007 | 704 | 0.010 |
Why?
| Analysis of Variance | 1 | 2006 | 1226 | 0.010 |
Why?
| Blood Proteins | 1 | 2005 | 232 | 0.010 |
Why?
| Phosphorylation | 1 | 2006 | 1571 | 0.010 |
Why?
| Motor Activity | 1 | 2006 | 640 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2005 | 1988 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2005 | 2791 | 0.010 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2000 | 38 | 0.010 |
Why?
| Premenopause | 1 | 2000 | 107 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2005 | 2321 | 0.010 |
Why?
| Signal Transduction | 1 | 2006 | 4521 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2000 | 1868 | 0.000 |
Why?
|
|
Cree's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|